N.Y. Times editorial board issues rare call to action to
N.Y. Times editorial board issues rare call to action to oppose GOP tax bill
< >
The New York Times editorial board openly urged voters to contact their congressional representatives to express opposition to the Senate GOP tax reform bill on Wednesday, a rare move by one of the most prominent editorial boards in the country.
"This morning, The New York Times Editorial Board is tweeting here to urge the Senate to reject a tax bill that hurts the middle class & the nation's fiscal health," the board wrote on The New York Times opinion section's official Twitter account.
The @nytopinion account's Twitter bio was changed to say the editorial board was "temporarily taking over" the platform.
In a series of tweets, the account listed the phone numbers for the congressional offices of several key Republican senators in the ongoing debate over the GOP tax bill. They included Sens. Jeff Flake and John McCain of Arizona, Susan Collins of Maine, Lisa Murkowski of Alaska, Bob Corker of Tennessee, James Lankford of Oklahoma and Jerry Moran of Kansas.
The seven lawmakers are considered to be persuadable votes in the GOP's effort to overhaul the tax code, though some in the group have indicated they will support the bill.
It was not immediately clear whether The New York Times editorial board, which is separate from the news division, has ever directly called on constituents to oppose a bill by listing the phone numbers for their representatives. But the move signaled a rare call to action by the group, which has grown increasingly antagonistic to Republican efforts on tax reform.
In an editorial published Tuesday, the opinion writers blasted the "enormously unpopular tax bill" which "lavishes benefits on corporations and wealthy families
Republican senators have a choice. They can follow the will of their donors and vote to take money from the middle class and give it to the wealthiest people in the world. Or they can vote no, to protect the public and the financial health of the government. There’s no compromise on that," the editorial board wrote.
A representative for The Times told POLITICO on Wednesday that the editorial board's actions weren't substantively different from its everyday work, but that the social media takeover was mostly an attempt to expand its efforts onto a different platform.
"The Editorial Board has been writing for weeks about concerns over the tax legislation Republican senators have a choice. They can follow the will of their donors and vote to take money from the middle class and give it to the wealthiest people in the world. Or they can vote no, to protect the public and the financial health of the government. There’s no compromise on that," the editorial board wrote.
A representative for The Times told POLITICO on Wednesday that the editorial board's actions weren't substantively different from its everyday work, but that the social media takeover was mostly an attempt to expand its efforts onto a different platform.
"The Editorial Board has been writing for weeks about concerns over the tax legislation pending in Congress," senior vice president of communications Eileen Murphy said in a statement. "This was an experiment in using a different platform to get that message out. We emphasized to our audience that this was the position of the Editorial Board in particular, not of Times Opinion generally." pending in Congress," senior vice president of communications Eileen Murphy said in a statement. "This was an experiment in using a different platform to get that message out. We emphasized to our audience that this was the position of the Editorial Board in particular, not of Times Opinion generally."
Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP
Scroll down for more posts ▼
Top 10 Most Recent News Articles
The AI Agent Arms Race is On Throwdown time in the AI jungle, folks. A new AI agent hit the big 10.9 million downloads in a mere six weeks. In the digital world, those kinds of numbers are the equivalent of finding a unicorn in your backyard. This data gem comes courtesy of Sensor Tower, as reported by Yahoo Finance, and it looks like the appetite for this technological...
Continue Reading
IBM's Strategic Bet on Enterprise Automation Diving into the blazing 2026 market, IBM Ventures has thrown its weight behind Leena AI, an enterprise agentic AI firm that's out to shake things up. You see, the name of the game isn't just flashy AI chatbots anymore. Companies like Leena AI are setting their sights on the back-office grunt work—the lifeblood operations in...
Continue Reading
Old School Meets New Tech: SQUID's 'Awardable' Moment In an era drowning in data, IESE Solutions throws us a lifeline with its SQUID platform—assessed 'Awardable' and now live on the Department of War's Chief Digital and Artificial Intelligence Office's (CDAO) Tradewinds Solutions Marketplace. Sounds technical, right? Well, let’s dive into why it matters for those...
Continue Reading
Aviation Marvel Now Anchored at Palm Springs There's something electric about standing next to a piece of history, especially when it involves the thunderous scream of an F/A-18 Super Hornet. The Palm Springs Air Museum is pulling back the curtains on an experience that's got aviation buffs and Top Gun fans buzzing like bees. On November 7, 2026, this central hub of...
Continue Reading
Lincoln Educational's Troubles Unravel You think you've seen it all, then boom—Lincoln Educational Services hit the skids with their stock diving close to 25% back in August 2026. This ain't your usual small hiccup; we’re talking a lawsuit filed and investors eyeing action as miserly as a broker when the market tumbles. News like this? It shakes the rafters of any...
Continue Reading
EV Chargers: The Future Parked Closer? I've been around the block more times than a cabbie in Manhattan rush hour, and let me tell you, when it comes to EVs, folks are still playing catch-up. But here's a kicker—LAZ Parking and indiGOtech have decided they're not gonna wait around. This joint venture of theirs aims to sock some sense into the old condo complex parking...
Continue Reading
Pushing Boundaries in Tumor Analysis with AI In the world of medical AI, it's not every day you hear about a tool that claims to read the secrets hidden within routine pathology slides to predict tumor behavior. Yet, here we are with Sophont's latest brainchild, the Holon-S1. This thing is more than just another AI model; it's a giant leap towards pulling the veil off...
Continue Reading
Lifemed AI and MEDITECH: A New Chapter in Healthcare You’d think by now the healthcare systems would be catching a break with technology, but here comes another twist. Lifemed AI and MEDITECH have banded together to tackle the notorious issue of claim denials head-on. Picture this: billions squandered every year because of avoidable administrative slip-ups. That's money...
Continue Reading
Hyliion's Rocky Partnership Sparks Market Concern If you've got your cash tied up in Hyliion Holdings Corp. (NYSE: HYLN), you've probably got an eye twitch by now. Last June, a damning report from Pelican Way Research threw a wrench in Hyliion's plans with VFG Holdings, calling into question the whole commercial rationale of their newest partnership. Imagine staking $133...
Continue Reading
Rocky Road in Identity Security Catch this: you're a security honcho, thinking you've forked over enough dough to lock down human and machine identities. But now, it turns out, most of your kind still don't have a full handle on who or what is poking around your systems. Talk about a wrench in the gears. This latest report from Oak drags the reality into the limelight:...
Continue Reading
Top 5 Most Recently Viewed Articles
Editas Medicine's Upcoming Presentation Highlights Editas Medicine, Inc. (NASDAQ: EDIT), a trailblazer in gene editing, is excited to announce that it will present at the renowned European Society of Gene and Cell Therapy (ESGCT) Congress. The congress is set to occur from October 7 to October 10, making this a significant occasion for the company and the field of gene...
Continue Reading
ICP DAS-BMP Showcases Medical Innovations at COMPAMED ICP DAS-BMP, a prominent manufacturer from Taiwan, is gearing up for the prestigious COMPAMED event taking place in Germany. This event, which draws significant attention from the medical device industry, showcases advancements in medical-grade thermoplastic polyurethane (TPU) materials. Focus on Low-Migration and...
Continue Reading
Broadcom's Recent Performance and Growth Potential Broadcom Inc. has made headlines recently with its remarkable performance in the tech sector. Following a solid earnings report for the second quarter, this semiconductor leader has seen its stock, designated as AVGO, score a notable jump of nearly 19% year-to-date. This surge has been particularly impressive, as the...
Continue Reading
InCarda Therapeutics Welcomes Dr. Myles Greenberg as CEO InCarda Therapeutics, a clinical-stage biopharmaceutical firm dedicated to developing cutting-edge treatments for cardiac arrhythmias, has appointed Dr. Myles Greenberg, MD, MBA, as its new Chief Executive Officer. Dr. Greenberg is set to lead the company as they work on their flagship product, an orally inhaled...
Continue Reading
Understanding Jim Cramer's Perspective on Nvidia CNBC’s Jim Cramer hinted at a potential turning point for NVIDIA Corp. (NASDAQ: NVDA) after the stock reached $127. This could signal a bottom for the semiconductor giant after its recent setbacks. Market Dynamics: What Cramer Noted Cramer’s Observations According to Cramer, the $127 mark could indicate a pivotal moment...
Continue Reading